Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan/Capecitabine vs Cisplatin/Capecitabine in Advanced Gastric Cancer
NCT00675194Phase 2Completed
- Sponsor
- Johannes Gutenberg University Mainz
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in gastric cancer (GC), gastroesophageal junction adenocarcinoma, sponsored by Johannes Gutenberg University Mainz. Started Oct 2003; status: completed.
02
Drugs
irinotecan
03
Conditions
gastric cancer (GC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT00675194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00675194.